Castle BiosciencesCSTL
那斯達克 · USD
32.66
-0.10
(-0.31%)
盤中 09/10 02:15 (UTC+8)
09/10 02:15 (UTC+8)
Castle BiosciencesCSTL
32.66
-0.10
(-0.31%)
財務數據
損益表
- 0.73
- 0.87
- 0.86
- 0.86
- 0.88
- 0.86
- 0.83
- 0.87
- 0.84
- 1.04
- 10.37
- 19.22
- -1.40
- 0.62
- 1.94
- -2.05
- -3.65
- 4.78
- -3.83
- 23.74
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 103,546 | 83,679 | 87,010 | 83,043 | 86,188 | 87,988 | 86,311 | 85,782 | 87,002 | 72,974 |
營業成本 | 23,700 | 20,533 | 18,315 | 18,704 | 17,626 | 16,383 | 16,183 | 15,609 | 14,519 | 13,894 |
營業毛利 | 79,846 | 63,146 | 68,695 | 64,339 | 68,562 | 71,605 | 70,128 | 70,173 | 72,483 | 59,080 |
營業費用 | 82,916 | 81,553 | 72,522 | 71,143 | 72,813 | - | - | - | - | - |
研發費用 | 14,543 | 14,428 | 13,515 | 12,960 | 12,787 | 12,588 | 11,773 | 12,323 | 14,136 | 13,809 |
推銷及管理費用 | 66,122 | 64,899 | 56,731 | 55,907 | 58,065 | 58,620 | 49,965 | 50,499 | 51,088 | 48,495 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 2,251 | 2,226 | 2,276 | 2,276 | 1,961 | 28,325 | 4,340 | 2,272 | 2,247 | 2,247 |
營業利益 | -3,070 | -18,407 | -3,827 | -6,804 | -4,251 | -27,928 | 4,050 | 5,079 | 5,012 | -5,471 |
其他收入及費用 | 2,203 | 2,106 | -329 | 6,202 | 2,704 | 1,674 | 3,927 | 3,404 | 3,144 | 2,996 |
利息費用 | 193 | 134 | 24 | 24 | 21 | 17 | 92 | 201 | 270 | 14 |
稅前純益 | -1,690 | -14,413 | -2,714 | -386 | -143 | -26,271 | 7,885 | 8,282 | 7,886 | -2,489 |
所得稅 | 370 | 109 | -382 | 115 | -4,666 | -423 | -1,705 | 6,013 | -1,034 | 45 |
稅後純益 | -2,060 | -14,522 | -2,332 | -501 | 4,523 | -25,848 | 9,590 | 2,269 | 8,920 | -2,534 |
基本每股稅後盈餘(元) | -0.07 | -0.49 | -0.08 | -0.02 | 0.16 | -0.90 | 0.34 | 0.08 | 0.32 | -0.09 |
稀釋每股稅後盈餘(元) | -0.06 | -0.49 | -0.07 | -0.02 | 0.16 | -0.90 | 0.32 | 0.08 | 0.31 | -0.09 |
基本平均股數(千股) | 30399.00 | 29889.00 | 29333.00 | 29073.00 | 28914.00 | 28609.00 | 28126.00 | 27840.00 | 27646.00 | 27485.00 |
稀釋平均股數(千股) | 30399.00 | 29889.00 | 29333.00 | 29073.00 | 29545.00 | 28609.00 | 30200.00 | 29401.00 | 28738.00 | 27485.00 |
還原基本每股稅後盈餘(元) | -0.07 | -0.49 | -0.08 | -0.02 | 0.16 | -0.90 | 0.34 | 0.08 | 0.32 | -0.09 |
還原稀釋每股稅後盈餘(元) | -0.06 | -0.49 | -0.07 | -0.02 | 0.16 | -0.90 | 0.32 | 0.08 | 0.31 | -0.09 |
還原基本平均股數(千股) | 30,399 | 29,889 | 29,333 | 29,073 | 28,914 | 28,609 | 28,126 | 27,840 | 27,646 | 27,485 |
還原稀釋平均股數(千股) | 30,399 | 29,889 | 29,333 | 29,073 | 29,545 | 28,609 | 30,200 | 29,401 | 28,738 | 27,485 |
EBITDA(千元) | 2,181 | -10,804 | 379 | 2,549 | 2,121 | 2,075 | 12,132 | 10,374 | 9,781 | -834 |